. . . . . . . . . . . "a(SCHEM:Mapatumumab) -> bp(MESHPP:Apoptosis)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Mapatumuma is fully human monoclonal antibodies that bind and activate TRAIL-1 [73], and mapatumuma treatment significantly inhibits lung cancer growth through inducing the apoptosis in in vitro as well as in vivo model [74]. " . . "Selventa" . . . . "2014-07-03T14:30:54.962+02:00"^^ . . .